We're looking at 2019 through the rearview mirror now, but before we turn our sights to 2020, it's worth taking a few moments to look back at the last year in international drug policy.
New Jersey legislators are making progress on two different fronts this week. (Creative Commons)
Facing criticism, Joe Biden walks back his marijuana "gateway theory" remarks; the FDA designated psilocybin therapy a "breakthrough therapy" for the second time, and more.
California's struggling legal marijuana industry will get another dose of taxation in the new year. (Creative Commons)
South Dakota medical marijuana and marijuana legalization campaigns turn in raw signatures, a California psychedelic decriminalization initiative gets updated, President Trump offers to "wage war" on Mexican drug cartels after an ambush left nine dual US-Mexican citzens dead, and more.
Andrew Yang and Beto O'Rourke both came out in support of drug decriminalization at Tuesday night's debate. (CNN screen grab)
A pair of Pennsylvania state senators have filed a marijuana legalization bill, the Mexican Senate prepares to vote on marijuana legalization, Amnesty International rips the Philippine drug war, and more.
It looks like the thousands of lawsuits against Purdue Pharma over Oxycontin are about to be settled, a new audit finds California's unlicensed pot shops greatly outnumber licensed ones, Florida's attorney general seeks to block a marijuana legalization initiative, and more.
Equipment to test controlled substances for contaminants would be decriminalized under a North Carolina bill. (SSDP)
The UN will probe drug war killings in the Philippines, murders in Mexico hit a monthly high, the North Carolina Opioid Epidemic Response Act is now on the governor's desk, and more.
Fentanyl and its analogues are the subject of a brewing battle in the Senate. (Creative Commons)
A battle over fentanyl analogues is brewing on Capitol Hill, various new drug laws went into effect yesterday, North Dakota marijuana advocates plan another initiative, and more.